Satellite symposia

The IDF Virtual Congress 2023 includes a series of high-level satellite symposia.

Renowned speakers will present their research followed by a Q&A session. The satellite symposia are scientifically oriented and reviewed by the Programme Committee for balance and rigour.

Don’t miss out on these excellent sources of additional education. They will also be available for view on-demand after the congress.

Monday, December 4
11:45-12:30
Point-of-Care breath ketone monitoring
Programme
Measuring breath ketone within a minute in a handy way with result comparable to the gold standard of Lab equipment GCFID

Christine Yip, Hong Kong
Prof Gary Tse, Hong Kong

Previous slide
Next slide
Tuesday, December 5
13:00-14:00
Real-Time CGM First
Programme
Why RT-CGM may be your primary prescription early in the diagnosis of type 2 diabetesand how to read the standard RT-CGM Ambulatory Glucose Profile (AGP) report

Thomas Grace, USA

Previous slide
Next slide
Tuesday, December 5
13:00-14:00
Harnessing the power of AI to help eliminate preventable blindness
Programme
Panel discussion on the evolution of eye screening technology, the new science of AI screening to provide health care professionals with data regarding AI screening and how it can impact clinical practice.

Chair: Andrew Boulton, UK

David Kerr, USA
Jennifer I. Lim, USA
Steven Yeh, USA

Supported by Eyenuk

Previous slide
Next slide
Wednesday, December 6
13:00-14:00
What’s New in MASLD: A diagnosis and management update for the busy clinician
Programme
Panel discussion on why MASLD/NASH is affecting a significant percentage of people with diabetes and a clear direction on the key diagnostic steps for MASLD that will lead to better patient management.

Chair: Kenneth Cusi, USA

Alina M. Allen, USA
Zobair M. Younossi, USA
Steven Yeh, USA

Supported by Novo Nordisk

Previous slide
Next slide
Monday, December 4
11:45-12:30
Point-of-Care breath ketone monitoring
Programme
Measuring breath ketone within a minute in a handy way with result comparable to the gold standard of Lab equipment GCFID

Christine Yip, Hong Kong
Prof Gary Tse, Hong Kong

Previous slide
Next slide
Tuesday, December 5
13:00-14:00
Real-Time CGM First
Programme
Why RT-CGM may be your primary prescription early in the diagnosis of type 2 diabetesand how to read the standard RT-CGM Ambulatory Glucose Profile (AGP) report

Thomas Grace, USA

Previous slide
Next slide
Tuesday, December 5
13:00-14:00
Harnessing the power of AI to help eliminate preventable blindness
Supported by Eyenuk
Programme
Panel discussion on the evolution of eye screening technology, the new science of AI screening to provide health care professionals with data regarding AI screening and how it can impact clinical practice.

Chair: Andrew Boulton, UK

David Kerr, USA
Jennifer I. Lim, USA
Steven Yeh, USA

Previous slide
Next slide
Wednesday, December 6
13:00-14:00
What’s New in MASLD: A diagnosis and management update for the busy clinician
Supported by Novo Nordisk
Programme
Panel discussion on why MASLD/NASH is affecting a significant percentage of people with diabetes and a clear direction on the key diagnostic steps for MASLD that will lead to better patient management.

Chair: Kenneth Cusi, USA

Alina M. Allen, USA
Zobair M. Younossi, USA
Steven Yeh, USA

Previous slide
Next slide
Tuesday, December 7
13:45-14:45
Oral Hypoglycaemic Agents Fact Checking - Adjusting treatment options to real-world practice
Programme

Co-Chairs: SP. Chan, Malaysia; David Matthews, UK

13:45-13:50: Introduction
David Matthews, UK

13:50-14:05: Glycemic control in T2D management: Why, When and How to reach targets?
David Matthews, UK

14:05-14:20: Gluco-centric and cardio-centric treatment options: 1 approach or both?
SP Chan, Malaysia

Programme

14:20-14:35: New Real-World Evidence on Sulphonylureas use in Asia – The JADE registry
L.L Lim, Malaysia

14:35-14:45: Conclusion
SP. Chan, Malaysia

Previous slide
Next slide
Wednesday, December 8
13:45-14:45
Modern management of refractory painful diabetic neuropathy Including high-frequency spinal cord stimulation
Programme

Chair: Rodica Pop-Busui, USA

13:45-13:50: Introduction and Educational Objectives
Rodica Pop-Busui, USA

13:50-14:05: Current management of pain in diabetic peripheral neuropathy
Gordon Smith, USA

14:05-14:20: Painful diabetic peripheral neuropathy: A guidance at last
Solomon Tesfaye, UK

Programme

14:20-14:35: Update of High-Frequency Spinal Cord Stimulation for Diabetic Peripheral Neuropathy
Erika Petersen, USA

14:35-14:45: Q&A

This programme is supported by an educational grant from Nevro Corp.

Previous slide
Next slide
Tuesday, December 7
13:45-14:45
From Outdated to Updated – Evolving with Real-Time CGM
Programme

Chair: Mei Wen Foo, Singapore

13:45-13:50: Introduction
Mei Wen Foo, Singapore

13:50-14:05: Keeping up with the evolution of CGM
Pieter Gillard, Belgium, Margaretha Visser, USA

14:05-14:20: Keeping up with the standard of care
Viral Shah, USA

14:20-14:35: Keeping up with what’s next
Grazia Aleppo, USA

Previous slide
Next slide
Thursday, December 9
13:45-14:45
Chronic kidney disease and Type 2 Diabetes: benefits of the MR antagonism
Programme

Chair: Peter Rossing, Denmark

13:45-13:50: Welcome and introduction
Peter Rossing, Denmark

13:50-14:05: Addressing unmet needs in chronic kidney disease and type 2 diabetes
Per-Henrik Groop, Finland

14:05-14:20: New renal and cardiovascular results with Finerenone
Alice Cheng, Canada

Programme

14:20-14:35: Chronic kidney disease and type 2 Diabetes: Clinical perspectives with nonsteroidal MR antagonists
Jennifer Green, USA

14:35-14:45: Discussion and closure

This programme is supported by a medical education grant from Bayer AG

Previous slide
Next slide
Cause and effect in diabetes and COVID-19
Programme

Chair: Clifford Bailey, UK

13:50-14:05: Impact of diabetes on COVID-19
Assoc. Prof. Aimee Andag-Silva, Philippines

14:05-14:20: Impact of COVID-19 on diabetes
Jean Claude Mbanya, Cameroon

14:20-14:35: Impact of metformin on COVID-19
Clifford Bailey, United Kingdom

Previous slide
Next slide
Friday, December 10
13:45-14:45
Topical Oxygen Therapy for Diabetic Foot Ulcers: New Evidence
Programme

Chair: David Armstrong, USA

13:45-13:50: Introduction and objectives
David Armstrong, USA

13:50-14:05: Development of oxygen therapy for diabetic foot ulcers over the last century
Thomas Wild, Germany

14:05-14:20: Topical oxygen therapies now have an evidence base
Robert Frykberg, USA

Programme

14:20-14:35: Modern management of complex diabetic foot ulcers
Michael Edmonds, UK

14:35-14:45: Q&A

This programme is supported by an educational grant from Advanced Oxygen Therapy Inc.

Previous slide
Next slide
Share
Share
Share